# Prospective Evaluation of PRP and BMC Treatment to Accelerate Healing After ACL Reconstruction

> **NCT04205656** · PHASE1,PHASE2 · ACTIVE_NOT_RECRUITING · sponsor: **Steadman Philippon Research Institute** · enrollment: 45 (actual)

## Conditions studied

- Osteoarthritis, Knee

## Interventions

- **BIOLOGICAL:** Leukocyte-Poor Platelet Rich Plasma (LP-PRP)
- **BIOLOGICAL:** Bone Marrow Concentrate (BMC)
- **OTHER:** Control group (Placebo)

## Key facts

- **NCT ID:** NCT04205656
- **Lead sponsor:** Steadman Philippon Research Institute
- **Sponsor class:** OTHER
- **Phase:** PHASE1,PHASE2
- **Study type:** INTERVENTIONAL
- **Status:** ACTIVE_NOT_RECRUITING
- **Start date:** 2020-01-02
- **Primary completion:** 2024-07
- **Final completion:** 2024-09
- **Target enrollment:** 45 (ACTUAL)
- **Last updated:** 2024-07-16

## Collaborators

- [object Object]
- [object Object]

## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT04205656

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT04205656, "Prospective Evaluation of PRP and BMC Treatment to Accelerate Healing After ACL Reconstruction". Retrieved via AI Analytics 2026-05-31 from https://api.ai-analytics.org/clinical/NCT04205656. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*